Nivolumab for metastatic renal cell carcinoma: Results of a randomized phase II trial

Robert J. Motzer, Brian I. Rini, David F. McDermott, Bruce G. Redman, Timothy M. Kuzel, Michael R. Harrison, Ulka N. Vaishampayan, Harry A. Drabkin, Saby George, Theodore F. Logan, Kim A. Margolin, Elizabeth R. Plimack, Alexandre M. Lambert, Ian M. Waxman, Hans J. Hammers

Research output: Contribution to journalArticlepeer-review

682 Scopus citations

Fingerprint Dive into the research topics of 'Nivolumab for metastatic renal cell carcinoma: Results of a randomized phase II trial'. Together they form a unique fingerprint.

Medicine & Life Sciences